Senior Statistician, Primary Care Clinical Trials Unit
Prior to joining Primary Care Clinical Trials Unit (PC-CTU), I worked at Centre for Statistics in Medicine where I was a trial statistician for a number of cancer clinical trials (predominantly randomised controlled trials). I first joined PC-CTU in 2013, where I was trial statistician for a number of trials including; ARCHIE, BARACK-D, StAR and EXPERT.
In 2014 I went to pursue a PhD in Population Health, focusing on HIV/HCV at University College London and completed in 2022. My research looked into the complication of managing HIV in relation to Hepatitis C in persons seen for routine clinical care in Italy. My research involved various data analysis of an Observational Cohort study of approximately 20,000 HIV-positive individuals.
During my PhD studies, I re-joined PC-CTU in 2018 and continued work in randomised controlled trials (DROPLET extension, SUMMIT-D, HABIT, INVICTUS; Respiratory illness related project – PRUDENCE, Value Dx; Mental health related projects; SOCWELL, PAX-D, Ebselen) and more recently involved in COVID-19 trials (PRINCIPLE, PANORAMIC, OCEANS III). I have also provided statistical consultancy for the Biomedical Research Council in Department of Psychiatry.
I have over 10 years experience as a medical statistician. I have worked in wide range of clinical areas, including but not limited to cancer, cardiovascular medicine, mental health and vaccine studies and respiratory.
I am also Research Adviser for the NIHR Research Design Service (South Central). I am also a member of the data and monitoring and trial steering committee of national trials as an independent statistician.
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
Shanyinde M. et al, (2019), BMC Public Health, 19
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study
Leone S. et al, (2018), European Journal of Clinical Microbiology and Infectious Diseases, 37, 871 - 881
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients
Saracino A. et al, (2018), PLoS ONE, 13
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
Monforte ADA. et al, (2017), PLoS ONE, 12
Are HIV/HCV co-infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the Icona Foundation study
Marchetti G. et al, (2016), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 19